Rankings
▼
Calendar
MRVI Q1 2025 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
MRVI
Maravai LifeSciences Holdings, Inc.
$999M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$47M
-27.0% YoY
Gross Profit
$8M
16.5% margin
Operating Income
-$49M
-104.9% margin
Net Income
-$30M
-63.9% margin
EPS (Diluted)
$-0.21
QoQ Revenue Growth
-16.9%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$15M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$960M
Total Liabilities
$429M
Stockholders' Equity
$301M
Cash & Equivalents
$285M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$47M
$64M
-27.0%
Gross Profit
$8M
$26M
-70.1%
Operating Income
-$49M
-$19M
-160.7%
Net Income
-$30M
-$12M
-147.9%
Revenue Segments
Nucleic Acid Production Segment
$29M
61%
Biologics Safety Testing Segment
$18M
39%
Geographic Segments
North America
$29M
62%
Asia Pacific
$11M
23%
EMEA
$7M
15%
Latin And Central America
$146,000
0%
← FY 2025
All Quarters
Q2 2025 →